Clinical Trials Sponsored by California Institute of Integral Studies

Total 2611 results

University of Southern California
National Cancer Institute (NCI)

Withdrawn

Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumor | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Premenopausal

United States
University of Southern California
National Cancer Institute (NCI)

Active, not recruiting

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | ALK Gene Mutation | EGFR Gene Mutation | Metastatic Head and Neck... and other conditions

United States
University of Southern California
National Cancer Institute (NCI)

Active, not recruiting

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Glioma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Stage IV Colon Cancer AJCC v8 and other conditions

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

HER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

Recurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
University of California, Berkeley
National Eye Institute (NEI)

Completed

An Active Approach to Treat Amblyopia: Perceptual Learning and Video Games

Amblyopia

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers

Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC...

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer

Colon Carcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Pancreatic Carcinoma

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients

Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Hormone-Resistant Prostate Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

High-Intensity Interval Training for Stage I-III Breast Cancer Patients

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer

United States
University of California, Irvine
Kenya Medical Research Institute

Completed

Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence (LLML)

Malaria

Kenya
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors

Cancer Survivor | No Evidence of Disease | Central Obesity

United States
University of California, Irvine
National Cancer Institute (NCI)

Terminated

Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis

Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation Therapy

Breast Carcinoma | Cancer Survivor

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

Lymphoma | Breast Carcinoma | Colon Carcinoma | Kidney Carcinoma | Prostate Carcinoma | Non-Small Cell Lung Carcinoma

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Prostate Cancer Stage I AJCC V6 | Prostate Cancer Stage II | Prostate Cancer Stage III

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Exercise Program for Early Breast Cancer Survivors

Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid Leukemia

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Questionnaires and Cognitive Assessments Following Mammography

Health Status Unknown

United States
University of California, Davis
National Cancer Institute (NCI)

Completed

Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants

Ovarian Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Exercise Program During Chemotherapy in Metastatic Colorectal Cancer

Stage IV Colorectal Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute... and other conditions

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer

Stage II Bladder Urothelial Carcinoma
University of California, Davis
National Cancer Institute (NCI)

Terminated

Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis (UCDCC#217)

Prostate Cancer | Metastatic Cancer

United States
California Institute of Renal Research
Imprimis Pharmaceuticals, Inc.

Completed

Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients

Arteriovenous Fistula

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid

Malignant Neoplasm | Musculoskeletal Complications

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Strength Training and Nutrition Development for African American Youth (STAND)

Obesity | Cancer | Type 2 Diabetes | Cardiovascular Risk

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Multiple Sclerosis | Metastatic Malignant Neoplasm in the Brain | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult... and other conditions

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer

Recurrent Renal Cell Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Intraocular Melanoma | Melanoma (Skin)

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
University of Southern California
National Cancer Institute (NCI)

Completed

IM-862 in Treating Patients With Recurrent Ovarian Cancer

Ovarian Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Intraocular Melanoma | Melanoma (Skin)

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer

Pancreatic Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Intraocular Melanoma | Melanoma (Skin)

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Endoscopic Breast Surgery in Treating Patients With Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
University of California, Davis

Unknown

Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Lymphoma

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Study of a Smart Growth Community's Effect on Prevention of Obesity in Middle-, Moderately Low- and Low-Income Families

Obesity | Healthy, no Evidence of Disease | Weight Changes

United States
University of California, Davis
National Cancer Institute (NCI)

Completed

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of California, Davis
National Cancer Institute (NCI)

Completed

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Breast Cancer

United States
University of California, Davis
National Cancer Institute (NCI)

Completed

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
University of California, Irvine
National Cancer Institute (NCI)

Completed

Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit

Cervical Intraepithelial Neoplasia

United States
University of California, Los Angeles
Orchard Therapeutics; California Institute for Regenerative Medicine (CIRM)

Completed

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

Severe Combined Immunodeficiency Due to ADA Deficiency

United States
Peter Stock
California Institute for Regenerative Medicine (CIRM)

Recruiting

Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes (PARADIGM)

Type 1 Diabetes

United States
University of Southern California
National Cancer Institute (NCI); California Breast Cancer Research Program

Completed

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Lobular Breast Carcinoma in Situ

United States

Clinical Trials Sponsored by California Institute of Integral Studies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations